IRF3 and neoplasm: Tumor necrosis factor-α (TNF-α) secreted by immune cells is well known to be capable of directly killing tumor cells, while IL-1β triggers can regulate adaptive immune responses via interferon regulatory factor 3 (IRF3) activation and IFN production, presenting a potent immune response against tumor cells [39].